| Firm | Analyst |
|---|---|
| BofA Securities | Jason Gerberry |
| Cantor Fitzgerald | Louise Chen |
| Chardan | Matthew Barcus |
| Citi Research | Samantha Semenkow |
| Credit Suisse | Tiago Fauth |
| Guggenheim | Yatin Suneja |
| HC Wainwright | Douglas Tsao |
| LifeSci Capital | Sam Slutsky |
| Piper Sandler | Yasmeen Rahimi |
| Raymond James | Danielle Brill |
| Stifel | Alex Thompson |
| SVB Leerink | Tom Smith |
| Truist | Robyn Karnauskas |
| UBS | Colin Bristow |
| Wells Fargo | Derek Archila |
Immunovant, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Immunovant, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Immunovant, Inc. or its management. Immunovant, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.